Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
22,272
Value
$376.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NTLA by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,272$376.8K<0.1%+892+4.2%AddedHolders
Q1 202621,380$274.1K<0.1%−2,534−10.6%ReducedHolders
Q4 202523,914$215.0K<0.1%+3,111+15.0%AddedHolders
Q3 202520,803$359.3K<0.1%−4,215−16.8%ReducedHolders
Q2 202525,018$234.7K<0.1%−1,620−6.1%ReducedHolders
Q1 202526,638$189.4K<0.1%−6,766−20.3%ReducedHolders
Q4 202433,404$389.5K<0.1%+9,196+38.0%AddedHolders
Q3 202424,208$497.5K<0.1%+6,245+34.8%AddedHolders
Q2 202417,963$402.0K<0.1%−5,272−22.7%ReducedHolders
Q1 202423,235$639.2K<0.1%+2,466+11.9%AddedHolders
Q4 202320,769$633.2K<0.1%+3,326+19.1%AddedHolders
Q3 202317,443$551.5K<0.1%+49+0.3%AddedHolders
Q2 202317,394$709.3K<0.1%+1,111+6.8%AddedHolders
Q1 202316,283$606.9K<0.1%−2,452−13.1%ReducedHolders
Q4 202218,735$653.7K<0.1%+2,819+17.7%AddedHolders
Q3 202215,916$890.0K<0.1%+391+2.5%AddedHolders
Q2 202215,525$804.0K<0.1%−6,875−30.7%ReducedHolders
Q1 202222,400$1.63M<0.1%−5,052−18.4%ReducedHolders
Q4 202127,452$3.25M<0.1%+1,302+5.0%AddedHolders
Q3 202126,150$3.51M<0.1%−2,670−9.3%ReducedHolders
Q2 202128,820$4.67M<0.1%+4,820+20.1%AddedHolders
Q1 202124,000$1.93M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.